Latest Distributions News

Green Critical Minerals advances its Very High Density graphite technology with strong thermal performance validation, production scale-up, and strategic moves into global markets including a planned US listing.

ActivEX Limited reports progress on multiple Queensland mineral projects, including a major drilling campaign at Gilberton and advancing rare earth exploration, while managing its portfolio through asset sales and loan facility extensions.

Associate Global Partners Limited reported a 4.6% increase in funds under management to $1.464 billion for Q3 2025, driven by robust inflows and standout returns from its WCM strategies. The company also sustained positive operating cash flows for the fourth consecutive quarter.

Atomo Diagnostics reported strong commercial momentum in Q1 FY26, highlighted by a key FDA submission for its FebriDx test and a successful capital raise of $1.3 million. The company also showcased promising clinical data for its Active Syphilis test and expanded its HIV Self-Test distribution channels.

Nick Scali Limited reported a robust $62 million underlying profit for FY25, completed its UK acquisition equity raise, and announced key leadership changes as it eyes accelerated growth in FY26.

Centuria Industrial REIT has secured a landmark 10-year lease with Tesla, delivering a 133% re-leasing spread and deferring redevelopment plans, while pursuing a major data centre expansion in Victoria.

CVC Limited is contemplating a fresh offer of Capital Notes, potentially including a reinvestment option for existing holders, contingent on market and regulatory conditions.

L1 Group has completed its merger with Platinum Asset Management, forming a $16.9 billion investment powerhouse focused on stabilising funds under management and unlocking significant cost synergies.

L1 Group Limited has completed the audit of First Maven Pty Ltd’s FY25 financials and released the merged pro forma results combining Platinum Asset Management and L1 Capital. The merged entity reports $305 million in revenue and $177 million in adjusted EBIT, reflecting key merger adjustments and a complex reverse acquisition structure.

Orthocell has appointed MontsMed as the exclusive distributor for its nerve repair product Remplir™ in Hong Kong, marking a significant step in its Asian commercialisation strategy. This move opens access to the vast Guangdong-Hong Kong-Macao Greater Bay Area, complementing existing operations in Singapore and planned expansion in Thailand.

Carlton Investments reported a slight rise in net profit and an 8.7% increase in dividends for FY2025, while its investment portfolio grew nearly 60% over five years despite recent market fluctuations.

Canterbury Resources has successfully closed an oversubscribed Share Purchase Plan, raising $1.24 million to advance its copper-gold exploration projects across Australia and Papua New Guinea.